Global Automation in Biopharma Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Automation in Biopharma Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ1028545 | No. of Pages: 109 | Category: Telecom and IT
Publisher: GRD Survey | Date of Publish: Nov-2021
Executive Summary

According to GRD Survey data, the global Automation in Biopharma market was valued at  million US$ in 2020 and is expected to  million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Automation in Biopharma market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Automation in Biopharma in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Solution
    Software

Market Snapshot, By Application
    Large Pharmaceutical Factory
    Small and Medium-sized Pharmaceutical Factory
    Biopharmaceutical Laboratory
    Other

Main Market Players Analyzed in this report, including:
    Cytiva
    Schneider Electric
    ABB
    Sartorius
    Siemens
    Rockwell
    Zenith (Cognizant)
    Honeywell
    Werum
    Emerson
    COPA-DATA GmbH
    Yokogawa
    Mitsubishi Electric

The study objectives of this report are:
    To study and analyze the global Automation in Biopharma market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Automation in Biopharma market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Automation in Biopharma manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Automation in Biopharma market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Automation in Biopharma submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Automation in Biopharma are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Automation in Biopharma Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Automation in Biopharma Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Automation in Biopharma

3 3 Industrial Lift Cycle and Main Buyers Analysis
    3.1 Industry Life Cycle Analysis
    3.2 Key Buying Industries/Consumers
        3.2.1 Major Buyers in Large Pharmaceutical Factory
        3.2.2 Major Buyers in Small and Medium-sized Pharmaceutical Factory

4 Market Segment: by Type
    4.1 Automation in Biopharma Type Introduction
        4.1.1 Solution
        4.1.2 Software
    4.2 Global Automation in Biopharma Revenue by Type 2016-2021

5 Market Segment: by Application
    5.1 Automation in Biopharma Type Introduction
        5.1.1 Large Pharmaceutical Factory
        5.1.2 Small and Medium-sized Pharmaceutical Factory
        5.1.3 Biopharmaceutical Laboratory
        5.1.3 Other
    5.2 Global Automation in Biopharma Revenue by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Automation in Biopharma Market by Region
    6.2 North America Automation in Biopharma Market 2016-2021
    6.3 Europe Automation in Biopharma Market 2016-2021
    6.4 Asia Pacific Automation in Biopharma Market 2016-2021
    6.5 South America Automation in Biopharma Market 2016-2021
    6.6 Middle East and Africa Automation in Biopharma Market 2016-2021

7 North America
    7.1 North America Automation in Biopharma Market by Country 2016-2021
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Automation in Biopharma Market by Country 2016-2021
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Automation in Biopharma Market by Country 2016-2021
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Automation in Biopharma Market by Country 2016-2021
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Automation in Biopharma Market by Country 2016-2021
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Cytiva
        12.1.1 Cytiva Company Information
        12.1.2 Cytiva Automation in Biopharma Product Portfolio, Specification and Application
        12.1.3 Cytiva Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.1.4 Cytiva Key Development
    12.2 Schneider Electric
        12.2.1 Schneider Electric Company Information
        12.2.2 Schneider Electric Automation in Biopharma Product Portfolio, Specification and Application
        12.2.3 Schneider Electric Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.2.4 Schneider Electric Key Development
    12.3 ABB
        12.3.1 ABB Company Information
        12.3.2 ABB Automation in Biopharma Product Portfolio, Specification and Application
        12.3.3 ABB Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.3.4 ABB Key Development
    12.4 Sartorius
        12.4.1 Sartorius Company Information
        12.4.2 Sartorius Automation in Biopharma Product Portfolio, Specification and Application
        12.4.3 Sartorius Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.4.4 Sartorius Key Development
    12.5 Siemens
        12.5.1 Siemens Company Information
        12.5.2 Siemens Automation in Biopharma Product Portfolio, Specification and Application
        12.5.3 Siemens Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.5.4 Siemens Key Development
    12.6 Rockwell
        12.6.1 Rockwell Company Information
        12.6.2 Rockwell Automation in Biopharma Product Portfolio, Specification and Application
        12.6.3 Rockwell Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.6.4 Rockwell Key Development
    12.7 Zenith (Cognizant)
        12.7.1 Zenith (Cognizant) Company Information
        12.7.2 Zenith (Cognizant) Automation in Biopharma Product Portfolio, Specification and Application
        12.7.3 Zenith (Cognizant) Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.7.4 Rockwell Key Development
    12.9 Werum
        12.9.1 Werum Company Information
        12.9.2 Werum Automation in Biopharma Product Portfolio, Specification and Application
        12.9.3 Werum Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.9.4 Werum Key Development
    12.8 Honeywell
        12.8.1 Honeywell Company Information
        12.8.2 Honeywell Automation in Biopharma Product Portfolio, Specification and Application
        12.8.3 Honeywell Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.8.4 Honeywell Key Development
    12.11 COPA-DATA GmbH
        12.11.1 COPA-DATA GmbH Company Information
        12.11.2 COPA-DATA GmbH Automation in Biopharma Product Portfolio, Specification and Application
        12.11.3 COPA-DATA GmbH Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.11.4 COPA-DATA GmbH Key Development
    12.12 Yokogawa
        12.12.1 Yokogawa Company Information
        12.12.2 Yokogawa Automation in Biopharma Product Portfolio, Specification and Application
        12.12.3 Yokogawa Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.12.4 Yokogawa Key Development
    12.13 Mitsubishi Electric
        12.13.1 Mitsubishi Electric Company Information
        12.13.2 Mitsubishi Electric Automation in Biopharma Product Portfolio, Specification and Application
        12.13.3 Mitsubishi Electric Automation in Biopharma Revenue and Gross Margin (2019-2021)
        12.13.4 Mitsubishi Electric Key Development

13 Global Automation in Biopharma Market Forecast by Region by Type and by Application
    13.1 Global Automation in Biopharma Revenue Forecast 2022-2027
    13.2 Global Automation in Biopharma Forecast by Regions
    13.3 Global Automation in Biopharma Forecast by Type
    13.4 Global Automation in Biopharma Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com